MYEOV (myeloma overexpressed gene) drives colon cancer cell migration and is regulated by PGE2

Journal of Experimental and Clinical Cancer Research

Volumn 29, Issue 1, 2010, Pages

  Lawlor, Garrett ^a   Doran, Peter P ^b   MacMathuna, Padraic ^a   Murray, David W ^b  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

MYELOMA OVEREXPRESSED PROTEIN; PROSTAGLANDIN E2; PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; MESSENGER RNA; MYEOV PROTEIN, HUMAN; ONCOPROTEIN;

ARTICLE; CELL INVASION; CELL MIGRATION; COLORECTAL CANCER; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; WOUND HEALING; CELL MOTION; CELL PROLIFERATION; COLON TUMOR; DRUG ANTAGONISM; GENETICS; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLONIC NEOPLASMS; DINOPROSTONE; HUMANS; PROTO-ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 77953675859     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-29-81     Document Type: Article

References (17)

1. Detection of let-7a microRNA by real-time PCR in colorectal cancer: a single-centre experience from China. WJ Fang CZ Lin HH Zhang J Qian L Zhong N Xu, J Int Med Res 2007 35 5 716 723 17944059
2. A genetic model for colorectal tumorigenesis. ER Fearon B Vogelstein, Cell 1990 61 5 759 767 10.1016/0092-8674(90)90186-I 2188735
3. ETV4 and Myeov knockdown impairs colon cancer cell line proliferation and invasion. AC Moss G Lawlor D Murray D Tighe SF Madden AM Mulligan CO Keane HR Brady PP Doran P MacMathuna, Biochem Biophys Res Commun 2006 345 1 216 221 10.1016/j.bbrc.2006.04.094 16678123
4. Concurrent activation of a novel putative transforming gene, myeov, and cyclin D1 in a subset of multiple myeloma cell lines with t(11;14)(q13;q32). JW Janssen JW Vaandrager T Heuser A Jauch PM Kluin E Geelen PL Bergsagel WM Kuehl HG Drexler T Otsuki CR Bartram E Schuuring, Blood 2000 95 8 2691 2698 10753852
5. Different mechanisms of cyclin D1 overexpression in multiple myeloma revealed by fluorescence in situ hybridization and quantitative analysis of mRNA levels. K Specht E Haralambieva K Bink M Kremer S Mandl-Weber I Koch R Tomer H Hofler E Schuuring PM Kluin F Fend L Quintanilla-Martinez, Blood 2004 104 4 1120 1126 10.1182/blood-2003-11-3837 15090460
6. MYEOV, a gene at 11q13, is coamplified with CCND1, but epigenetically inactivated in a subset of esophageal squamous cell carcinomas. JW Janssen I Imoto J Inoue Y Shimada M Ueda M Imamura CR Bartram J Inazawa, J Hum Genet 2002 47 9 460 464 10.1007/s100380200065 12202983
7. MYEOV: a candidate gene for DNA amplification events occurring centromeric to CCND1 in breast cancer. JW Janssen M Cuny B Orsetti C Rodriguez H Vallés CR Bartram E Schuuring C Theillet, Int J Cancer 2002 102 6 608 614 10.1002/ijc.10765 12448002
8. Prostaglandin E(2) promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor delta. D Wang H Wang Q Shi S Katkuri W Walhi B Desvergne SK Das SK Dey RN DuBois, Cancer Cell 2004 6 3 285 295 10.1016/j.ccr.2004.08.011 15380519
9. Prostaglandins and cancer. D Wang RN DuBois, Gut 2006 55 1 115 122 10.1136/gut.2004.047100 16118353
10. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. CC Liang AY Park JL Guan, Nat Protoc 2007 2 2 329 333 10.1038/nprot.2007.30 17406593
11. Prostaglandin E2 increases growth and motility of colorectal carcinoma cells. H Sheng J Shao MK Washington RN DuBois, J Biol Chem 2001 276 21 18075 18081 10.1074/jbc.M009689200 11278548
12. Prostaglandin E2 induces fibroblast growth factor 9 via EP3-dependent protein kinase Cdelta and Elk-1 signaling. PC Chuang HS Sun TM Chen SJ Tsai, Mol Cell Biol 2006 26 22 8281 8292 10.1128/MCB.00941-06 16982695
13. Prostaglandin E2 stimulates the growth of colon cancer cells via induction of amphiregulin. J Shao SB Lee H Guo BM Evers H Sheng, Cancer Res 2003 63 17 5218 5223 14500348
14. PGE2 up-regulates vascular endothelial growth factor expression in MKN28 gastric cancer cells via epidermal growth factor receptor signaling system. YB Ding RH Shi JD Tong XY Li GX Zhang WM Xiao JG Yang Y Bao J Wu ZG Yan XH Wang, Exp Oncol 2005 27 2 108 113 15995627
15. ABC of colorectal cancer: Epidemiology. P Boyle JS Langman, BMJ 2000 321 7264 805 808 10.1136/bmj.321.7264.805 11009523
16. Prostaglandin E2 increases growth and motility of colorectal carcinoma cells. H Sheng J Shao MK Washington RN DuBois, J Biol Chem 2001 276 18075 18081 10.1074/jbc.M009689200 11278548
17. Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor. FG Buchanan D Wang F Bargiacchi RN DuBois, J Biol Chem 2003 278 37 35451 7 (2003) 10.1074/jbc.M302474200 12824187